Sensei Biotherapeutics (NASDAQ:SNSE) Posts Quarterly Earnings Results, Meets Estimates

Sensei Biotherapeutics (NASDAQ:SNSE) issued its quarterly earnings data on Friday. The company reported ($0.27) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.27), Zacks reports.

Sensei Biotherapeutics Stock Up 18.0 %

Shares of SNSE stock traded up $0.08 during trading hours on Friday, reaching $0.51. 145,672,542 shares of the stock traded hands, compared to its average volume of 898,433. Sensei Biotherapeutics has a 1-year low of $0.38 and a 1-year high of $1.94. The firm has a market capitalization of $12.78 million, a PE ratio of -0.43 and a beta of 0.16. The business has a fifty day moving average price of $0.47 and a 200 day moving average price of $0.49.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SNSE. HC Wainwright reiterated a “buy” rating and set a $4.00 price target on shares of Sensei Biotherapeutics in a research report on Friday. Oppenheimer upped their price target on shares of Sensei Biotherapeutics from $3.50 to $4.00 and gave the company an “outperform” rating in a report on Friday.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.